Drug Treatment Center - Endocyte Begins Phase II Clinical Trial of EC145 For Treatment of - Phramalive.com

Endocyte Begins Phase II Clinical Trial of EC145 For Treatment of - Phramalive.com
WEST LAFAYETTE, Ind.–(BUSINESS WIRE)–Feb 19, 2009 - Endocyte Inc. has announced the initiation of a randomized Phase II clinical study of the company’s investigational drug EC145 in women with platinum-resistant ovarian cancer. The phase II trial

New ‘bubble’ targets only cancer cells - PhysOrg
For millions of Americans with cancer, the side effects of chemotherapy and other treatment drugs can be devastating. But new drug-delivery research based on nano- and microtechnology from Tel Aviv University might provide much-needed relief, as well

Medtronic Receives FDA HDE Approval to Commercialize the First Deep - Genetic Engineering News
Medtronic, Inc. ( NYSE: MDT ), announced today its official entrance into psychiatric therapies with approval from the U.S. Food and Drug Administration (FDA) for a humanitarian device exemption (HDE) for its Reclaim™ Deep Brain Stimulation (DBS

ImaRx’s Ultrasound Stroke Treatment, After Devastating Setback - Xconomy
Biotech , Stroke , Ultrasound ImaRx’s Ultrasound Stroke Treatment, After Devastating Setback, Beats Clot-Busting Drug in Study Luke Timmerman 2/19/09 ImaRx Therapeutics, the Redmond, WA-based developer of an ultrasound-based treatment for stroke

Genesis closure leaves huge gap - Medford Mail Tribune
Drug and alcohol treatment specialists across Jackson County were talking Thursday about how to fill the void that will open when the Genesis recovery center in Central Point closes in April. “Genesis has been a part of this community for 23 years

Gene test helps set accurate blood thinner dose - WNYT
(AP) ATLANTA - People taking warfarin, a leading blood thinner to prevent clots that cause heart attacks and strokes, soon may have a better way to get the tricky dose right. A new formula that includes gene testing proved much better at setting the

A drug may improve memory in elderly - United Press International
People who read this also read Test helps evaluate Alzheimer’s driving Insulin might become Alzheimer’s treatment Diabetes doubles Alzheimer’s risk Apple juice may delay Alzheimer’s disease Alzheimer’s aggression can be threatening Anti

The Fight For Sobriety Starts With An Effective Drug Rehab Program - Transworld News
There is no substitute for personal attention in the addiction recovery process. The fact of the matter is that no two rehab patients are ever exactly alike, and no rehab center should ever treat them as if they were. Those clinics which fail to

Endocyte Begins Phase II Clinical Trial of EC145 For Treatment of - Phramalive.com
WEST LAFAYETTE, Ind.–(BUSINESS WIRE)–Feb 19, 2009 - Endocyte Inc. has announced the initiation of a randomized Phase II clinical study of the company’s investigational drug EC145 in women with platinum-resistant ovarian cancer. The phase II trial

New ‘bubble’ targets only cancer cells - PhysOrg
For millions of Americans with cancer, the side effects of chemotherapy and other treatment drugs can be devastating. But new drug-delivery research based on nano- and microtechnology from Tel Aviv University might provide much-needed relief, as well

Medtronic Receives FDA HDE Approval to Commercialize the First Deep - Genetic Engineering News
Medtronic, Inc. ( NYSE: MDT ), announced today its official entrance into psychiatric therapies with approval from the U.S. Food and Drug Administration (FDA) for a humanitarian device exemption (HDE) for its Reclaim™ Deep Brain Stimulation (DBS

ImaRx’s Ultrasound Stroke Treatment, After Devastating Setback - Xconomy
Biotech , Stroke , Ultrasound ImaRx’s Ultrasound Stroke Treatment, After Devastating Setback, Beats Clot-Busting Drug in Study Luke Timmerman 2/19/09 ImaRx Therapeutics, the Redmond, WA-based developer of an ultrasound-based treatment for stroke

Genesis closure leaves huge gap - Medford Mail Tribune
Drug and alcohol treatment specialists across Jackson County were talking Thursday about how to fill the void that will open when the Genesis recovery center in Central Point closes in April. “Genesis has been a part of this community for 23 years

Gene test helps set accurate blood thinner dose - WNYT
(AP) ATLANTA - People taking warfarin, a leading blood thinner to prevent clots that cause heart attacks and strokes, soon may have a better way to get the tricky dose right. A new formula that includes gene testing proved much better at setting the

A drug may improve memory in elderly - United Press International
People who read this also read Test helps evaluate Alzheimer’s driving Insulin might become Alzheimer’s treatment Diabetes doubles Alzheimer’s risk Apple juice may delay Alzheimer’s disease Alzheimer’s aggression can be threatening Anti

The Fight For Sobriety Starts With An Effective Drug Rehab Program - Transworld News
There is no substitute for personal attention in the addiction recovery process. The fact of the matter is that no two rehab patients are ever exactly alike, and no rehab center should ever treat them as if they were. Those clinics which fail to

Leave a Reply